4//SEC Filing
Clague Laura 4
Accession 0001209191-22-005080
CIK 0001438533other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:34 PM ET
Size
5.1 KB
Accession
0001209191-22-005080
Insider Transaction Report
Form 4
Clague Laura
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-01-24$24.98/sh−2,063$51,534→ 29,253 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001388773
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:34 PM ET
- Size
- 5.1 KB